Håkan Mellstedt

13.7k total citations · 1 hit paper
298 papers, 9.9k citations indexed

About

Håkan Mellstedt is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Håkan Mellstedt has authored 298 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Immunology, 128 papers in Genetics and 80 papers in Oncology. Recurrent topics in Håkan Mellstedt's work include Chronic Lymphocytic Leukemia Research (123 papers), Lymphoma Diagnosis and Treatment (70 papers) and Immunotherapy and Immune Responses (70 papers). Håkan Mellstedt is often cited by papers focused on Chronic Lymphocytic Leukemia Research (123 papers), Lymphoma Diagnosis and Treatment (70 papers) and Immunotherapy and Immune Responses (70 papers). Håkan Mellstedt collaborates with scholars based in Sweden, Iran and France. Håkan Mellstedt's co-authors include Anders Österborg, Magnus Björkholm, Anders Österborg, G. Holm, Mahmood Jeddi‐Tehrani, Eva Kimby, Jeanette Lundin, Göran Holm, Mikael Jondal and Jan‐Erik Frödin and has published in prestigious journals such as Nature, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Håkan Mellstedt

296 papers receiving 9.6k citations

Hit Papers

Therapeutic vaccines for cancer: an overview of clinical ... 2014 2026 2018 2022 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutic vaccines for cancer: an overview of clinical trials
    2014 614 citations Håkan Mellstedt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Håkan Mellstedt Sweden 51 5.4k 3.5k 2.8k 2.7k 2.2k 298 9.9k
Arnold S. Freedman United States 50 3.8k 0.7× 3.4k 1.0× 2.5k 0.9× 1.8k 0.7× 3.8k 1.7× 188 9.7k
Marinus H. J. van Oers Netherlands 53 3.2k 0.6× 2.8k 0.8× 2.4k 0.9× 1.9k 0.7× 2.8k 1.3× 175 9.0k
Larry W. Kwak United States 61 6.2k 1.2× 4.9k 1.4× 1.6k 0.6× 3.9k 1.4× 3.2k 1.5× 319 12.6k
Jeffrey Cossman United States 46 2.9k 0.5× 2.9k 0.8× 2.4k 0.8× 3.3k 1.2× 3.4k 1.6× 112 9.3k
Kenneth A. Foon United States 44 3.5k 0.7× 3.5k 1.0× 3.2k 1.1× 2.3k 0.8× 2.6k 1.2× 190 10.3k
Manlio Ferrarini Italy 49 7.0k 1.3× 1.9k 0.6× 7.2k 2.6× 3.1k 1.1× 5.2k 2.3× 245 13.0k
Steven L. Allen United States 45 4.5k 0.8× 1.9k 0.5× 6.4k 2.3× 3.2k 1.2× 4.5k 2.0× 225 11.4k
Wolfram Brugger Germany 51 3.7k 0.7× 4.7k 1.3× 1.9k 0.7× 2.9k 1.1× 2.2k 1.0× 191 10.6k
Livio Trentin Italy 49 3.6k 0.7× 1.9k 0.5× 2.4k 0.9× 1.8k 0.7× 2.5k 1.1× 332 8.6k
Peter Vandenberghe Belgium 58 2.7k 0.5× 2.2k 0.6× 1.6k 0.6× 3.1k 1.1× 2.4k 1.1× 229 10.7k

Countries citing papers authored by Håkan Mellstedt

Since Specialization
Citations

This map shows the geographic impact of Håkan Mellstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkan Mellstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkan Mellstedt more than expected).

Fields of papers citing papers by Håkan Mellstedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Håkan Mellstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkan Mellstedt. The network helps show where Håkan Mellstedt may publish in the future.

Co-authorship network of co-authors of Håkan Mellstedt

This figure shows the co-authorship network connecting the top 25 collaborators of Håkan Mellstedt. A scholar is included among the top collaborators of Håkan Mellstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Håkan Mellstedt. Håkan Mellstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hojjat‐Farsangi, Mohammad, Ann Svensson, Jeanette Lundin, et al.. (2023). A CX3CR1 (fractalkine receptor) Small Molecular Antagonist (KAND567) Suppressed the Growth Promoting Effect of Monocytes on Chronic Lymphocytic Leukemia Cells. Blood. 142(Supplement 1). 5716–5716. 1 indexed citations
2.
Andersson, Maria, Jinghua Wu, David Wullimann, et al.. (2023). Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia. Journal of Hematology. 12(4). 170–175. 3 indexed citations
3.
Hojjat‐Farsangi, Mohammad, Amir Hossein Daneshmanesh, Fariba Mozaffari, et al.. (2017). First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells. Blood. 130. 4320–4320. 1 indexed citations
4.
Mellstedt, Håkan, Mohammad Hojjat‐Farsangi, Amir Hossein Daneshmanesh, et al.. (2016). First generation of a small chemical molecule ROR1 RTK tyrosine kinase inhibitor. Annals of Oncology. 27. vi530–vi530. 3 indexed citations
5.
Mozaffari, Fariba, et al.. (2014). Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients. International Journal of Oncology. 45(3). 1293–1303. 59 indexed citations
6.
Mellstedt, Håkan. (2013). Anti-neoplastic biosimilars—the same rules as for cytotoxic generics cannot be applied. Annals of Oncology. 24. v23–v28. 16 indexed citations
7.
Daneshmanesh, Amir Hossein, Anna Porwit, Mohammad Hojjat‐Farsangi, et al.. (2012). Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies. Leukemia & lymphoma. 54(4). 843–850. 63 indexed citations
8.
Bagnara, Davide, Matthew Kaufman, Carlo Calissano, et al.. (2011). A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood. 117(20). 5463–5472. 145 indexed citations
9.
Zech, L. & Håkan Mellstedt. (2008). Chromosome 13… new marker for B-cell chronic lymphocytic leukemia. Hereditas. 108(1). 77–84. 3 indexed citations
10.
11.
Mellstedt, Håkan, Dietger Niederwieser, & Heinz Ludwig. (2007). The challenge of biosimilars. Annals of Oncology. 19(3). 411–419. 203 indexed citations
12.
Österborg, Anders, Claes Karlsson, Jeanette Lundin, Eva Kimby, & Håkan Mellstedt. (2006). Strategies in the Management of Alemtuzumab-Related Side Effects. Seminars in Oncology. 33(2 Suppl 5). 29–35. 43 indexed citations
13.
Mosolits, Szilvia, Bo Nilsson, & Håkan Mellstedt. (2005). Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Review of Vaccines. 4(3). 329–350. 47 indexed citations
14.
Lundin, Jeanette, Eva Kimby, Magnus Björkholm, et al.. (2001). Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).. Blood. 98. 4 indexed citations
15.
Mellstedt, Håkan. (1994). Induction of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Antibodies Against Exogenous Nonglycosylated GM-CSF: Biological Implications. Journal of Interferon Research. 14(4). 179–180. 6 indexed citations
16.
Aguilar‐Santelises, Miguel, Håkan Mellstedt, & Mikael Jondal. (1994). Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro.. PubMed. 8(7). 1146–52. 19 indexed citations
17.
Aguilar‐Santelises, Miguel, S.B. Svenson, Annika Loftenius, et al.. (1991). Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression.. PubMed Central. 84(3). 422–8. 29 indexed citations
18.
19.
Wersäll, Peter, Giuseppe Masucci, & Håkan Mellstedt. (1991). Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity. Cancer Immunology Immunotherapy. 33(1). 45–49. 10 indexed citations
20.
Österborg, Anders, Maria G. Masucci, Susanne Bergenbrant, et al.. (1991). Generation of T cell clones binding F(ab′)2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy. Cancer Immunology Immunotherapy. 34(3). 157–162. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnold S. Freedman Breakdown of academic impact, for papers by Marinus H. J. van Oers Breakdown of academic impact, for papers by Larry W. Kwak Breakdown of academic impact, for papers by Jeffrey Cossman Breakdown of academic impact, for papers by Kenneth A. Foon Breakdown of academic impact, for papers by Manlio Ferrarini Breakdown of academic impact, for papers by Steven L. Allen Breakdown of academic impact, for papers by Wolfram Brugger Breakdown of academic impact, for papers by Livio Trentin Breakdown of academic impact, for papers by Peter Vandenberghe
Rankless by CCL
2026